https://www.marketscreener.com/quote/stock/GALECTO-INC-114282637/news/Galecto-Inc-Announces-First-Patient-Dosed-in-an-Investigator-Initiated-Phase-2-Trial-of-GB1211-in-46598966/?utm_source=telegram&utm_medium=social&utm_campaign=share